Diagnostic imaging company RadNet (NASDAQ:RDNT) will be announcing earnings results next tomorrow afternoon. Here’s what to expect. RadNet beat analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $498.2 million, up 8.4% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and an impressive beat of analysts’ same-store sales estimates. Is RadNet a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge me ...